Peptides8 min read·Published October 28, 2026

Is BPC-157 a PED? What Athletes Should Know

BPC-157 is not a steroid, but it is an unapproved peptide that can create serious eligibility, testing, and health risks for athletes.

Is BPC-157 a PED? What Athletes Should Know

BPC-157 is not a classic anabolic steroid, but athletes should treat it as a prohibited performance-related substance. USADA places it under the World Anti-Doping Agency’s S0 Non-Approved Substances category, and it is not FDA-approved for any medical use. Its limited human evidence, unknown safety profile, and testing risk make it a poor fit for competitive sport. 1

Wondering if peptide therapy is right for you? Take the 3-min clinical quiz.

See if you qualify →

Is BPC-157 considered a PED?

Yes, in the practical sense that matters to athletes. A performance-enhancing drug (PED) is broader than an anabolic steroid: it can include a substance used or marketed to affect recovery, training capacity, or performance. BPC-157 is prohibited in sport because it is an unapproved substance, not because it is known to work like testosterone. 1

Short answer for athletes

If you compete under rules that follow the WADA Prohibited List, do not assume BPC-157 is allowed because it is described online as a “recovery peptide” or because it is not a steroid. USADA specifically identifies BPC-157 as prohibited under S0, the category for non-approved substances. 1

Why PED can mean more than steroids

Steroids are one type of PED. Peptides, hormones, stimulants, blood-modifying agents, and unapproved drugs may also be prohibited depending on the rules of a sport. The key issue is not whether a product looks like a steroid; it is whether it is permitted under the applicable anti-doping code. 1

How BPC-157 fits into banned-substance rules

S0 is designed to capture substances that are not approved for human therapeutic use by a government health authority. That category can include substances sold as research-use-only peptides or offered through other channels. Product marketing does not override sport rules, and athletes remain responsible for substances found in their samples. 1

What is BPC-157?

BPC-157, or Body Protection Compound-157, is a synthetic version of a peptide sequence associated with research on gastric juice. It is often called a stable gastric pentadecapeptide because it contains 15 amino acids. It has no FDA-approved indication or approved brand-name medicine. 1

Online marketing often calls BPC-157 a regenerative peptide and makes claims about tendon healing, muscle injury, ligament injury, bone healing, or gut health. Those claims run ahead of the human evidence. A sports-medicine review found that the published literature was overwhelmingly preclinical, with 35 preclinical studies and one clinical study in its included evidence base. 2

That distinction matters. “Research-use-only” does not mean a product has been evaluated for safe human use, purity, dose consistency, or effectiveness. 1 Our guide to research-only peptides versus prescription access explains why a product label is not the same thing as clinical oversight.

Why is BPC-157 banned in sport?

BPC-157 is prohibited because anti-doping rules can ban non-approved substances before there is proof that they enhance performance. The relevant category is S0 Non-Approved Substances, not the anabolic-agent category used for many steroids. 1

This approach protects both fair competition and athlete health. When a substance has not been adequately studied in people, officials may not know its full effects, interactions, detection window, or long-term risks. Reviews of unapproved peptide therapies also emphasize major gaps in human safety and clinical evidence. 7

QuestionWhat the evidence or rules support
Is BPC-157 a steroid?No. It is a synthetic pentadecapeptide, not an anabolic steroid. 1
Can it still be prohibited?Yes. USADA identifies it as prohibited under WADA S0 Non-Approved Substances. 1
Is it FDA-approved?No. There is no FDA-approved BPC-157 medicine for any indication. 1
Does animal research prove human recovery benefits?No. Animal and cell findings cannot establish safe or effective human treatment. 2

Does BPC-157 show up on a drug test?

Athletes should assume BPC-157 can create an anti-doping problem rather than rely on claims that it is “undetectable.” Testing methods and detection capability change over time, and a negative result on a consumer drug screen is not the same as an anti-doping result. 1

We cannot predict whether a specific athlete will test positive, qualify for a therapeutic use exemption, or face a sanction. Before taking any peptide, contact your sport governing body, anti-doping organization, or team medical staff. This is especially important for NCAA, professional, Olympic, and military-associated athletes, who may be subject to different policies.

Be cautious with supplement and research-peptide labels. Labels may not fully describe what is in a product, and online sourcing adds uncertainty about identity, concentration, contamination, and sterility. 7 For a broader safety checklist, read where to get peptide injections safely.

Does BPC-157 affect testosterone or hormones?

There is no reliable human evidence that BPC-157 increases testosterone or improves hormone levels. No established human testosterone benefit exists for BPC-157. Reviews describe possible signaling effects in preclinical research, but those findings do not establish a hormone effect in people. 2 7

Some laboratory and animal work has explored pathways related to growth hormone receptor expression, inflammatory cytokines, angiogenesis, and VEGFR2-Akt-eNOS signaling. These are proposed mechanisms, not proof of improved testosterone, strength, recovery, or athletic performance in humans. 2

What does the evidence say about BPC-157 for healing or recovery?

The honest answer is that BPC-157 has interesting preclinical findings but very limited clinical evidence. Most available BPC-157 research is animal or cell research, so it cannot establish that BPC-157 safely speeds healing in people. 2

Cell and animal evidence

A 2011 cell study found that BPC-157 affected tendon outgrowth, cell survival, and cell migration in tendon fibroblast research. That is useful for understanding a possible mechanism, but it is not a human clinical outcome. 3

Animal studies have examined BPC-157 in models of tissue injury, blood-vessel disruption, and gastrointestinal injury. For example, a 2022 study examined vascular and ischemia-reperfusion injury models in rats. Animal results can guide future research, but they do not prove that the same effect will occur in people. 4

Human evidence and registered trials

Registered studies include a Phase 1 safety and pharmacokinetics listing with 42 participants, a not-yet-recruiting 30-person rotator cuff repair study, and a recruiting Phase 2 hamstring-strain study planned for 120 participants. These listings show research interest, not established safety or effectiveness. 5 6 8

If you are managing a real injury, evidence-based diagnosis and rehabilitation remain important. Our peptides for muscle recovery guide separates promising theories from established recovery care.

What are the health and quality risks of BPC-157?

The main health concern is uncertainty. Long-term human safety is unknown, and there is not enough high-quality human evidence to establish safe use for injury recovery, performance, or hormone effects. 2 7

  • Possible risks include side effects that have not been well characterized in humans, drug interactions, and delayed evaluation of a significant injury. 7
  • Products sold online may have uncertain identity, concentration, purity, or sterility—especially if intended for research rather than patient care. 1
  • An injectable product adds route-specific concerns, including contamination and injection-related complications when it is not obtained through appropriate medical care. 7

What should athletes do before taking any peptide?

Start with the rules and the medical problem—not the marketing. Check your organization’s current policy before using any peptide, supplement, or compounded product. Anti-doping policies can change, and one sport’s rules may not match another’s. 1

  1. 1Check the current prohibited list and your league, school, team, or service policy.
  2. 2Ask a licensed clinician to evaluate a new or ongoing injury, especially if there is weakness, swelling, instability, numbness, fever, or loss of function.
  3. 3Use official anti-doping resources for eligibility and medication questions rather than social posts, influencer advice, or seller claims.
  4. 4Avoid treating a research-use-only label as a safety or quality guarantee.

What is Chia’s perspective on BPC-157 and safer peptide access?

Chia does not offer BPC-157 or compounded BPC-157. We believe athletes and patients deserve a clear distinction between promising early research and treatments with enough human evidence to support routine medical use.

When someone is considering peptides for recovery, longevity, weight, or another health goal, a licensed clinician can help identify the actual problem, review medications and risks, and discuss appropriate options. At Chia, our online care model uses a health questionnaire and licensed-provider review for treatments in our live catalog only; a prescription is never guaranteed. Medications we prescribe are compounded by state-licensed US 503A pharmacies and shipped to the patient’s door, and compounded medications are not FDA-approved.

For education about another peptide often discussed in sports settings, see our evidence review of the TB4 peptide. If you have a recovery or longevity goal that may warrant medical care, you can also talk with a Chia provider through our online eligibility quiz.

Frequently asked questions about BPC-157 and sports

References

  1. 1.United States Anti-Doping Agency. BPC-157: Experimental Peptide Creates Risk for Athletes. USADA, accessed 2026.
  2. 2.Emerging Use of BPC-157 in Orthopaedic Sports Medicine. Systematic review. 2025.
  3. 3.Chang CH, Tsai WC, Lin MS, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2011.
  4. 4.Sikiric P, Skrtic A, Gojkovic S, et al. Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome. World Journal of Gastroenterology. 2022.
  5. 5.ClinicalTrials.gov. PCO-02 - Safety and Pharmacokinetics Trial (NCT02637284). ClinicalTrials.gov, accessed 2026.
  6. 6.ClinicalTrials.gov. BPC 157 for Acute Hamstring Muscle Strain Repair (NCT07437547). ClinicalTrials.gov, accessed 2026.
  7. 7.Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Medicine. 2026.
  8. 8.ClinicalTrials.gov. Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery (NCT07803250). ClinicalTrials.gov, accessed 2026.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if peptide therapy is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides